Why the study?
Does NT-proBNP measurement improve prognostic risk stratification for mortality in patients with NSTE-ACS compared to TIMI risk score and ACC/AHA classification alone?
Population
1483 consecutive patients with non-ST-segment-elevation acute coronary syndromes (NSTE-ACS)
Design
Cohort
Follow-up
180 days
Authors
Loading...
NT-proBNP may refine mortality risk stratification in NSTE-ACS; leaves open prospective validation against TIMI and ACC/AHA scores.
Does NT-proBNP measurement improve prognostic risk stratification for mortality in patients with NSTE-ACS compared to TIMI risk score and ACC/AHA classification alone?
NT-proBNP is a strong independent predictor of short- and medium-term mortality in NSTE-ACS, adding significant prognostic value beyond standard clinical risk scores.
Óscar Bazzino (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: